BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Busk TM, Bendtsen F, Henriksen JH, Fuglsang S, Clemmesen JO, Larsen FS, Møller S. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on blood volume distribution in patients with cirrhosis. Dig Liver Dis 2017;49:1353-9. [PMID: 28729141 DOI: 10.1016/j.dld.2017.06.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Schmidt WFJ, Wachsmuth N, Jimenez J, Soria R. Hemoglobin Mass and Blood Volume in Patients With Altitude-Related Polycythemia. Front Physiol 2022;13:867108. [PMID: 35574463 DOI: 10.3389/fphys.2022.867108] [Reference Citation Analysis]
2 Manguso G, Vignone A, Merli M, Miotti C, Caputo A, Vizza CD, Badagliacca R. Hemodynamic Evaluation of the Right Heart-Pulmonary Circulation Unit in Patients Candidate to Transjugular Intrahepatic Portosystemic Shunt. JCM 2022;11:461. [DOI: 10.3390/jcm11020461] [Reference Citation Analysis]
3 Pitton MB, Weinmann A, Kloeckner R, Mittler J, Ruckes C, Düber C, Otto G. Transjugular Portosystemic Stent Shunt: Impact of Right Atrial Pressure on Portal Venous Hemodynamics Within the First Week. Cardiovasc Intervent Radiol 2022;45:102-11. [PMID: 34853873 DOI: 10.1007/s00270-021-03003-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Yao X, Zhou H, Huang S, Tang SH, Qin JP. Effects of transjugular intrahepatic portosystemic shunt using the Viatorr stent on hepatic reserve function in patients with cirrhosis. World J Clin Cases 2021; 9(7): 1532-1542 [PMID: 33728297 DOI: 10.12998/wjcc.v9.i7.1532] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Ge J, Lai JC, Boike JR, German M, Jest N, Morelli G, Spengler E, Said A, Lee A, Hristov A, Desai AP, Junna S, Pokhrel B, Couri T, Paul S, Frenette C, Christian-Miller N, Laurito M, Verna EC, Rahim U, Goel A, Das A, Pine S, Gregory D, VanWagner LB, Kolli KP; Advancing Liver Therapeutic Approaches (ALTA) Study Group. Nonalcoholic Fatty Liver Disease and Diabetes Mellitus Are Associated With Post-Transjugular Intrahepatic Portosystemic Shunt Renal Dysfunction: An Advancing Liver Therapeutic Approaches Group Study. Liver Transpl 2021;27:329-40. [PMID: 33217178 DOI: 10.1002/lt.25949] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Rostambeigi N, Farsad K, Young S, Shrestha P, Jahangiri Y, Liang KW, Cretcher M, Golzarian J. Lower-Extremity Edema Is Common after Transjugular Intrahepatic Portosystemic Shunt Creation and Is Associated with Lower Survival: A Two-Institution Study. Radiology 2021;298:221-7. [PMID: 33201792 DOI: 10.1148/radiol.2020201690] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Hiroyama S, Rokugawa T, Ito M, Iimori H, Morita I, Maeda H, Fujisawa K, Matsunaga K, Shimosegawa E, Abe K. Quantitative evaluation of hepatic integrin αvβ3 expression by positron emission tomography imaging using 18F-FPP-RGD2 in rats with non-alcoholic steatohepatitis. EJNMMI Res 2020;10:118. [PMID: 33026561 DOI: 10.1186/s13550-020-00704-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Steib CJ, Li H, Zhang J, Mayerle J, Ricke J, Gerbes AL, Meyer C, Zipprich A, Trebicka J. Transjugular intrahepatic portosystemic shunt for patients with liver cirrhosis: survey evaluating indications, standardization of procedures and anticoagulation in 43 German hospitals. European Journal of Gastroenterology & Hepatology 2020;32:1179-85. [DOI: 10.1097/meg.0000000000001628] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
9 Yao CK, Fung J, Chu NHS, Tan VPY. Dietary Interventions in Liver Cirrhosis. J Clin Gastroenterol. 2018;52:663-673. [PMID: 29912757 DOI: 10.1097/mcg.0000000000001071] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
10 Dissegna D, Sponza M, Falleti E, Fabris C, Vit A, Angeli P, Piano S, Cussigh A, Cmet S, Toniutto P. Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis. Eur J Gastroenterol Hepatol. 2019;31:626-632. [PMID: 30550458 DOI: 10.1097/meg.0000000000001342] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
11 Kok B, Abraldes JG. Patient Selection in Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Refractory Ascites and Associated Conditions. Curr Hepatology Rep 2019;18:197-205. [DOI: 10.1007/s11901-019-00470-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
12 Yi T, Ma W, Qiu J, Ding W. Pulmonary hypertension with massive megalosplenia: A case report. Medicine (Baltimore) 2019;98:e14594. [PMID: 30896614 DOI: 10.1097/MD.0000000000014594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Liu J, Chen D. Correlations of MMP-2 and MMP-9 gene polymorphisms with the risk of hepatopulmonary syndrome in cirrhotic patients: A case-control study. The Kaohsiung Journal of Medical Sciences 2018;34:634-42. [DOI: 10.1016/j.kjms.2018.06.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
14 European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406-460. [PMID: 29653741 DOI: 10.1016/j.jhep.2018.03.024] [Cited by in Crossref: 660] [Cited by in F6Publishing: 822] [Article Influence: 165.0] [Reference Citation Analysis]